Clinical Trial Update: Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 efficacy trial of MPC-7869 for Alzheimer's disease and dementia. Results are not specified in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• MPC-7869

Snippet

Sponsor: Myrexis Inc. | Conditions: Alzheimer Disease, Dementia | Phase 3 | Status: COMPLETED